iRhythm Technologies Inc
Change company Symbol lookup
Select an option...
IRTC iRhythm Technologies Inc
GSBD Goldman Sachs BDC Inc
LTRN Lantern Pharma Inc
JGGC Jaguar Global Growth Corporation I
WHG Westwood Holdings Group Inc
BNOX Bionomics Ltd
PSO Pearson PLC
ERNA Eterna Therapeutics Inc
INDP Indaptus Therapeutics Inc
TSLX Sixth Street Specialty Lending Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

iRhythm Technologies, Inc. is a digital healthcare company that is engaged in providing ambulatory electrocardiogram (ECG) monitoring for patients for arrhythmias. The Company has developed a portfolio of ambulatory cardiac monitoring services on a platform, called the Zio service. Zio service consists of wearable patch-based biosensors, Zio XT and Zio AT monitors, which records and stores ECG data from every patient heartbeat for up to 14 consecutive days. Zio service then provides cloud-based analysis of the recorded cardiac rhythms using its algorithms, an assessment review of the data by its cardiographic technicians, a report called Zio report, which includes the summary of findings and finally its cloud-based digital information system, ZioSuite, allows clinicians to connect via a Web browser or mobile application for online report interpretation and clinical workflows. The Company's cloud-based data analytic platform to help physicians monitor patients and diagnose arrhythmias.

Closing Price
$96.08
Day's Change
4.83 (5.29%)
Bid
--
Ask
--
B/A Size
--
Day's High
97.79
Day's Low
90.78
Volume
(Heavy Day)
Volume:
916,075

10-day average volume:
447,226
916,075

Company Profile

iRhythm Technologies, Inc. is a digital healthcare company that is engaged in providing ambulatory electrocardiogram (ECG) monitoring for patients for arrhythmias. The Company has developed a portfolio of ambulatory cardiac monitoring services on a platform, called the Zio service. Zio service consists of wearable patch-based biosensors, Zio XT and Zio AT monitors, which records and stores ECG data from every patient heartbeat for up to 14 consecutive days. Zio service then provides cloud-based analysis of the recorded cardiac rhythms using its algorithms, an assessment review of the data by its cardiographic technicians, a report called Zio report, which includes the summary of findings and finally its cloud-based digital information system, ZioSuite, allows clinicians to connect via a Web browser or mobile application for online report interpretation and clinical workflows. The Company's cloud-based data analytic platform to help physicians monitor patients and diagnose arrhythmias.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
6.17x
Price/Book (MRQ)
12.45x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

September 2023
Current Month
2.3M
Previous Month
2.3M
Percent of Float
7.71%
Days to Cover
6.5809 Days

Share Information

IRTC is in a share class of common stock
Float
30.3M
Shares Outstanding
30.6M
Institutions Holding Shares
277
105.92%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • Abhijit Y. Talwalkar
  • Quentin S. BlackfordPres.
  • Brice BobzienCFO
  • Reyna M. Fernandez
  • Minang TurakhiaExec.VP

Address

Insider Trading

During the most recent quarter, 11K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.